- Home
- EFR vs GOSS Comparison
EFR vs GOSS Comparison
Compare EFR & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFR
- GOSS
- Stock Information
- Founded
- EFR 2003
- GOSS 2015
- Country
- EFR United States
- GOSS United States
- Employees
- EFR N/A
- GOSS N/A
- Industry
- EFR Trusts Except Educational Religious and Charitable
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- EFR Finance
- GOSS Health Care
- Exchange
- EFR Nasdaq
- GOSS Nasdaq
- Market Cap
- EFR 344.0M
- GOSS 347.8M
- IPO Year
- EFR N/A
- GOSS 2019
- Fundamental
- Price
- EFR $11.71
- GOSS $2.47
- Analyst Decision
- EFR
- GOSS Strong Buy
- Analyst Count
- EFR 0
- GOSS 4
- Target Price
- EFR N/A
- GOSS $8.50
- AVG Volume (30 Days)
- EFR 88.6K
- GOSS 3.1M
- Earning Date
- EFR 01-01-0001
- GOSS 08-05-2025
- Dividend Yield
- EFR 9.43%
- GOSS N/A
- EPS Growth
- EFR N/A
- GOSS N/A
- EPS
- EFR 1.69
- GOSS N/A
- Revenue
- EFR N/A
- GOSS $40,237,000.00
- Revenue This Year
- EFR N/A
- GOSS N/A
- Revenue Next Year
- EFR N/A
- GOSS $30.65
- P/E Ratio
- EFR $7.74
- GOSS N/A
- Revenue Growth
- EFR N/A
- GOSS N/A
- 52 Week Low
- EFR $10.95
- GOSS $0.66
- 52 Week High
- EFR $13.29
- GOSS $2.65
- Technical
- Relative Strength Index (RSI)
- EFR 43.60
- GOSS 68.08
- Support Level
- EFR $11.64
- GOSS $2.38
- Resistance Level
- EFR $11.79
- GOSS $2.65
- Average True Range (ATR)
- EFR 0.09
- GOSS 0.15
- MACD
- EFR 0.01
- GOSS 0.03
- Stochastic Oscillator
- EFR 60.00
- GOSS 76.67
About EFR Eaton Vance Senior Floating-Rate Fund of Beneficial Interest
Eaton Vance Senior Floating Rate Trust is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income. As a secondary objective, the fund intends to seek capital preservation. Its portfolio of investments consists of Software, Health Care Providers & Services, Machinery, Chemicals, Professional Services, IT Services, Hotels, Restaurants & Leisure, Capital Markets, Specialty Retail, Commercial Services & Supplies, and other areas. The trust invests in below investment grade floating rate loans, which are considered speculative because of the credit risk of their issuers.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.